PhillyPharma Archive: January, 2013

With lower litigation costs, J&J says fourth quarter net earnings rose more than 1000 percent

Comment icon 0 Comments
Helped by dramatically lower litigation costs, health-care giant Johnson & Johnson said Tuesday that its net earnings rose to $2.57 billion... Read more

Doctor on shifting causes of death: 'Automobile era' to the 'pharmaceutical era'

Comment icon 0 Comments
Dr. Jeanmarie Perrone, whose specialties are emergency medicine and toxicology, said in an interview last week that we have changed eras when... Read more

Kittens in SEC filings? Pfizer pegs Zoetis IPO at $22 to $25 per share

Comment icon 0 Comments
Drugmaker Pfizer filed a notice with the Securities and Exchange Commission estimating that its spinoff of its animal drug business called... Read more

FTC report says pharma companies engaged in record 40 pay-to-delay deals

Comment icon 0 Comments
The Federal Trade Commission is not at all pleased with pharmaceutical companies, branded and generic alike. The FTC's basic mission is to... Read more

Finding better ways to treat disease in developing countries

Comment icon 0 Comments
Allan Pamba is the director of engagement and access initiatives in GlaxoSmithKline's Developing Countries Market Access Unit. Before he went... Read more

Teva hires Olympian Apolo Anton Ohno to talk about exercise-induced bronchospasm

Comment icon 0 Comments
One of the cultural trend-setters in the soul patch category, Olympic short-track speed skater Apolo Anton Ohno will try to help Teva Pharmaceuticals... Read more

Neglected diseases get some attention

Comment icon 0 Comments
In marking the first anniversary of their gathering, the groups and drug companies involved in the London Declaration on Neglected Tropical... Read more

AstraZeneca shakes up leadership under new CEO Pascal Soriot

Comment icon 0 Comments
Pascal Soriot, the still-new chief executive officer of AstraZeneca, said Tuesday that he was changing the leadership lineup below his spot... Read more